Alterity Therapeutics to Participate in the Sachs Associates 5th Annual Neuroscience Innovation Forum March 15, 2022August 16, 2022
Alterity Therapeutics Granted New Composition of Matter Patent in Europe for Neurodegenerative Diseases including Parkinson’s and Alzheimer’s August 23, 2023August 23, 2023